Similar results from multiple groups [10, 11, 12] and the effectiveness of immunotherapies against tau in mouse models [13] have now led to a general recognition that transcellular propagation of pathology could underlie pathogenesis of tauopathies and other amyloidoses. Here, MAPT is linked to tauopathy.